Study finds weakness in drug-resistant tuberculosis pathogens

A University of Otago-led study has found highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering a new way to kill them.

Amgen scores late-stage trial success for eczema and myasthenia gravis treatments, but faces stiff competition

Amgen on Tuesday reported that a pair of antibody drugs it is developing as treatments for immune-mediated diseases succeeded in late-stage trials, but the therapies

September 24, 2024

Teen Vaping Hits 10-Year Low in the U.S.

Fewer adolescents are vaping this year than at any point in the last decade, government officials reported Thursday, pointing to a shrinking number of high

September 6, 2024

What Drug Did an FDA Panel Deem Ineffective?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

September 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.